Pregnane X receptor and natural products: beyond drug–drug interactions

• MANGELSDORF DJ, THUMMEL C, BEATO M et al.: The nuclear receptor superfamily: the second decade. Cell (1995) 83(6):835-839.
   PubMed Web of Science ®Google Scholar
• KLIEWER SA, MOORE JT, WADE L et al.: An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell (1998) 92(1):73-82.
   PubMed Web of Science ®Google Scholar
• BLUMBERG B, SABBAGH W Jr, JUGUILON H et al.: SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev. (1998) 12(20):3195-3205.
   PubMed Web of Science ®Google Scholar
• LEHMANN JM, MCKEE DD, WATSON MA et al.: The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest. (1998) 102(5):1016-1023.
   PubMed Web of Science ®Google Scholar
• MOORE LB, MAGLICH JM, MCKEE DD et al.: Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors. Mol. Endocrinol. (2002) 16(5):977-986.
   PubMed Web of Science ®Google Scholar
• MAGLICH JM, STOLTZ CM, GOODWIN B et al.: Nuclear pregnane X receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol. Pharmacol. (2002) 62(3):638-646.
   PubMed Web of Science ®Google Scholar
• ROSENFELD JM, VARGAS R Jr, XIE W, EVANS RM: Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. Mol. Endocrinol. (2003) 17(7):1268-1282.
   PubMed Web of Science ®Google Scholar
• STAUDINGER J, LIU Y, MADAN A, HABEEBU S, KLAASSEN CD: Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab. Dispos. (2001) 29(11):1467-1472.
   PubMed Web of Science ®Google Scholar
• STAUDINGER JL, GOODWIN B, JONES SA et al.: The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. USA (2001) 98(6):3369-3374.
   PubMed Web of Science ®Google Scholar
• STAUDINGER JL, MADAN A, CAROL KM, PARKINSON A: Regulation of drug transporter gene expression by nuclear receptors. Drug Metab. Dispos. (2003) 31(5):523-527.
   PubMed Web of Science ®Google Scholar
• GOODWIN B, REDINBO MR, KLIEWER SA: Regulation of cyp3a gene transcription by the pregnane x receptor. Ann. Rev. Pharmacol. Toxicol. (2002) 42:1-23.
   PubMed Web of Science ®Google Scholar
• KLIEWER SA, GOODWIN B, WILLSON TM: The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr. Rev. (2002) 23(5):687-702.
   PubMed Web of Science ®Google Scholar
• CHEN C, STAUDINGER JL, KLAASSEN CD: Nuclear receptor, pregnane X receptor, is required for induction of UDP-glucuronosyltranferases in mouse liver by pregnenolone-16 alpha-carbonitrile. Drug Metab. Dispos. (2003) 31(7):908-915.
   PubMed Web of Science ®Google Scholar
• PASCUSSI JM, ROBERT A, NGUYEN M et al.: Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J. Clin. Invest. (2005) 115(1):177-186.
   PubMed Web of Science ®Google Scholar
• SONODA J, XIE W, ROSENFELD JM et al.: Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc. Natl. Acad. Sci. USA (2002) 99(21):13801-13806.
   PubMed Web of Science ®Google Scholar
• WEI P, ZHANG J, DOWHAN DH, HAN Y, MOORE DD: Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response. Pharmacogenomics J. (2002) 2(2):117-126.
   PubMedGoogle Scholar
• GEICK A, EICHELBAUM M, BURK O: Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J. Biol. Chem. (2001) 276(18):14581-14587.
   PubMed Web of Science ®Google Scholar
• KAST HR, GOODWIN B, TARR PT et al.: Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J. Biol. Chem. (2002) 277(4):2908-2915.
   PubMed Web of Science ®Google Scholar
• SAINI SP, MU Y, GONG H et al.: Dual role of orphan nuclear receptor pregnane X receptor in bilirubin detoxification in mice. Hepatology (2005) 41(3):497-505.
   PubMed Web of Science ®Google Scholar
• SONODA J, CHONG LW, DOWNES M et al.: Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites. Proc. Natl. Acad. Sci. USA (2005) 102(6):2198-2203.
   PubMed Web of Science ®Google Scholar
• ZHOU C, ASSEM M, TAY JC et al.: Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J. Clin. Invest. (2006) 116(6):1703-1712.
   PubMed Web of Science ®Google Scholar
• XIE W, YEUH MF, RADOMINSKA-PANDYA A et al.: Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc. Natl. Acad. Sci. USA (2003) 100(7):4150-4155.
   PubMed Web of Science ®Google Scholar
• WATKINS RE, WISELY GB, MOORE LB et al.: The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science (2001) 292(5525):2329-2333.
   PubMed Web of Science ®Google Scholar
• SYNOLD TW, DUSSAULT I, FORMAN BM: The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat. Med. (2001) 7(5):584-590.
   PubMed Web of Science ®Google Scholar
• DING X, LICHTI K, STAUDINGER JL: The mycoestrogen zearalenone induces CYP3A through activation of the pregnane X receptor. Toxicol. Sci. (2006) 91(2):448-455.
   PubMed Web of Science ®Google Scholar
• PUIGSERVER P, ADELMANT G, WU Z et al.: Activation of PPARgamma coactivator-1 through transcription factor docking. Science (1999) 286(5443):1368-1371.
   PubMed Web of Science ®Google Scholar
• SPENCER TE, JENSTER G, BURCIN MM et al.: Steroid receptor coactivator-1 is a histone acetyltransferase. Nature (1997) 389(6647):194-198.
   PubMed Web of Science ®Google Scholar
• XIE HG, KIM RB: St John’s Wort-associated drug interactions: short-term inhibition and long-term induction? Clin. Pharmacol. Ther. (2005) 78(1):19-24.
   PubMed Web of Science ®Google Scholar
• MOORE LB, GOODWIN B, JONES SA et al.: St. John’s Wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl. Acad. Sci. USA (2000) 97(13):7500-7502.
   PubMed Web of Science ®Google Scholar
• WENTWORTH JM, AGOSTINI M, LOVE J, SCHWABE JW, CHATTERJEE VK: St John’s Wort, a herbal antidepressant, activates the steroid X receptor. J. Endocrinol. (2000) 166(3):R11-R16.
   PubMed Web of Science ®Google Scholar
• RENGELSHAUSEN J, BANFIELD M, RIEDEL KD et al.: Opposite effects of short-term and long-term St John’s Wort intake on voriconazole pharmacokinetics. Clin. Pharmacol. Ther. (2005) 78(1):25-33.
   PubMed Web of Science ®Google Scholar
• OBACH RS: Inhibition of human cytochrome P450 enzymes by constituents of St. John’s Wort, an herbal preparation used in the treatment of depression. J. Pharmacol. Exp. Ther. (2000) 294(1):88-95.
   PubMed Web of Science ®Google Scholar
• DEV S: Ancient-modern concordance in Ayurvedic plants: some examples. Environ. Health Perspect. (1999) 107(10):783-789.
   PubMed Web of Science ®Google Scholar
• BEG M, SINGHAL KC, AFZAAL S: A study of effect of guggulsterone on hyperlipidemia of secondary glomerulopathy. Indian J. Physiol. Pharmacol. (1996) 40(3):237-240.
   PubMedGoogle Scholar
• SINGH V, KAUL S, CHANDER R, KAPOOR NK: Stimulation of low density lipoprotein receptor activity in liver membrane of guggulsterone treated rats. Pharmacol. Res. (1990) 22(1):37-44.
   PubMed Web of Science ®Google Scholar
• URIZAR NL, LIVERMAN AB, DODDS DT et al.: A natural product that lowers cholesterol as an antagonist ligand for FXR. Science (2002) 296(5573):1703-1706.
   PubMed Web of Science ®Google Scholar
• SZAPARY PO, WOLFE ML, BLOEDON LT et al.: Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial. JAMA (2003) 290(6):765-772.
   PubMed Web of Science ®Google Scholar
• BROBST DE, DING X, CREECH KL et al.: Guggulsterone activates multiple nuclear receptors and induces CYP3A gene expression through the pregnane X receptor. J. Pharmacol. Exp. Ther. (2004) 310(2):528-535.
   PubMed Web of Science ®Google Scholar
• BURRIS TP, MONTROSE C, HOUCK KA et al.: The hypolipidemic natural product guggulsterone is a promiscuous steroid receptor ligand. Mol. Pharmacol. (2005) 67(3):948-954.
   PubMed Web of Science ®Google Scholar
• DALVI SS, NAYAK VK, POHUJANI SM et al.: Effect of gugulipid on bioavailability of diltiazem and propranolol. J. Assoc. Physicians India (1994) 42(6):454-455.
   PubMedGoogle Scholar
• DING X, STAUDINGER JL: The ratio of constitutive androstane receptor to pregnane X receptor determines the activity of guggulsterone against the Cyp2b10 promoter. J. Pharmacol. Exp. Ther. (2005) 314(1):120-127.
   PubMed Web of Science ®Google Scholar
• BILIA AR, GALLON S, VINCIERI FF: Kava-kava and anxiety: growing knowledge about the efficacy and safety. Life Sci. (2002) 70(22):2581-2597.
   PubMed Web of Science ®Google Scholar
• MATHEWS JM, ETHERIDGE AS, BLACK SR: Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metab. Dispos. (2002) 30(11):1153-1157.
   PubMed Web of Science ®Google Scholar
• UNGER M, HOLZGRABE U, JACOBSEN W, CUMMINS C, BENET LZ: Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava). Planta Med. (2002) 68(12):1055-1058.
   PubMed Web of Science ®Google Scholar
• MA Y, SACHDEVA K, LIU J et al.: Desmethoxyyangonin and dihydromethysticin are two major pharmacological kavalactones with marked activity on the induction of CYP3A23. Drug Metab. Dispos. (2004) 32(11):1317-1324.
   PubMed Web of Science ®Google Scholar
• AMMON HP, MULLER AB: Forskolin: from an ayurvedic remedy to a modern agent. Planta Med. (1985) 6:473-477.
   PubMedGoogle Scholar
• SEAMON KB, PADGETT W, DALY JW: Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc. Natl. Acad. Sci. USA (1981) 78(6):3363-3367.
   PubMed Web of Science ®Google Scholar
• SIDHU JS, OMIECINSKI CJ: Forskolin-mediated induction of CYP3A1 mRNA expression in primary rat hepatocytes is independent of elevated intracellular cyclic AMP. J. Pharmacol. Exp. Ther. (1996) 276(1):238-245.
   PubMed Web of Science ®Google Scholar
• DING X, STAUDINGER JL: Induction of drug metabolism by forskolin: the role of the pregnane X receptor and the protein kinase a signal transduction pathway. J. Pharmacol. Exp. Ther. (2005) 312(2):849-856.
   PubMed Web of Science ®Google Scholar
• DOWLESS MS, BARBEE JL, BORCHERT KM, BOCCHINFUSO WP, HOUCK KA: Cyclic AMP-independent activation of CYP3A4 gene expression by forskolin. Eur. J. Pharmacol. (2005) 512(1):9-13.
   PubMed Web of Science ®Google Scholar
• MILLS E, COOPER C, SEELY D, KANFER I: African herbal medicines in the treatment of HIV: hypoxis and Sutherlandia. An overview of evidence and pharmacology. Nutr. J. (2005) 4:19.
   PubMed Web of Science ®Google Scholar
• MILLS E, FOSTER BC, VAN HEESWIJK R et al.: Impact of African herbal medicines on antiretroviral metabolism. AIDS (2005) 19(1):95-97.
   PubMed Web of Science ®Google Scholar
• VAN AGTMAEL MA, EGGELTE TA, VAN BOXTEL CJ: Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication. Trends Pharmacol. Sci. (1999) 20(5):199-205.
   PubMed Web of Science ®Google Scholar
• ASHTON M, HAI TN, SY ND et al.: Artemisinin pharmacokinetics is time-dependent during repeated oral administration in healthy male adults. Drug Metab. Dispos. (1998) 26(1):25-27.
   PubMed Web of Science ®Google Scholar
• HASSAN ALIN M, ASHTON M, KIHAMIA CM, MTEY GJ, BJORKMAN A: Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients. Trans. R. Soc. Trop. Med. Hyg. (1996) 90(1):61-65.
   PubMed Web of Science ®Google Scholar
• BURK O, ARNOLD KA, NUSSLER AK et al.: Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol. Pharmacol. (2005) 67(6):1954-1965.
   PubMed Web of Science ®Google Scholar
• MU Y, ZHANG J, ZHANG S et al.: Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats. J. Pharmacol. Exp. Ther. (2006) 316(3):1369-1377.
   PubMed Web of Science ®Google Scholar
• XIE W, RADOMINSKA-PANDYA A, SHI Y et al.: An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc. Natl. Acad. Sci. USA (2001) 98(6):3375-3380.
   PubMed Web of Science ®Google Scholar
• BACHS L, PARES A, ELENA M, PIERA C, RODES J: Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis. Lancet (1989) 1(8638):574-576.
   PubMed Web of Science ®Google Scholar
• CANCADO EL, LEITAO RM, CARRILHO FJ, LAUDANNA AA: Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gamma-glutamyl transpeptidase. Am. J. Gastroenterol. (1998) 93(9):1510-1517.
   PubMed Web of Science ®Google Scholar
• CROWN J, O’LEARY M: The taxanes: an update. Lancet (2000) 355(9210):1176-1178.
   PubMed Web of Science ®Google Scholar
• ECKARDT JR: Antitumor activity of docetaxel. Am. J. Health Syst. Pharm. (1997) 54(24 Suppl. 2):S2-S6.
   PubMedGoogle Scholar
• JACOBS MN, NOLAN GT, HOOD SR: Lignans, bacteriocides and organochlorine compounds activate the human pregnane X receptor (PXR). Toxicol. Appl. Pharmacol. (2005) 209(2):123-133.
   PubMed Web of Science ®Google Scholar
• LANDES N, PFLUGER P, KLUTH D et al.: Vitamin E activates gene expression via the pregnane X receptor. Biochem. Pharmacol. (2003) 65(2):269-273.
   PubMed Web of Science ®Google Scholar
• FAYETTE J, COQUARD IR, ALBERTI L et al.: ET-743: a novel agent with activity in soft-tissue sarcomas. Curr. Opin. Oncol. (2006) 18(4):347-353.
   PubMed Web of Science ®Google Scholar
• JIN S, GORFAJN B, FAIRCLOTH G, SCOTTO KW: Ecteinascidin-743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation. Proc. Natl. Acad. Sci. USA (2000) 97(12):6775-6779.
   PubMed Web of Science ®Google Scholar
• PUCHALSKI TA, RYAN DP, GARCIA-CARBONERO R et al.: Pharmacokinetics of ecteinascidin-743 administered as a 24-h continuous intravenous infusion to adult patients with soft tissue sarcomas: associations with clinical characteristics, pathophysiological variables and toxicity. Cancer Chemother. Pharmacol. (2002) 50(4):309-319.
   PubMed Web of Science ®Google Scholar
• HUANG W, ZHANG J, CHUA SS et al.: Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc. Natl. Acad. Sci. USA (2003) 100(7):4156-4161.
   PubMed Web of Science ®Google Scholar
• KAWAMOTO T, SUEYOSHI T, ZELKO I et al.: Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol. Cell. Biol. (1999) 19(9):6318-6322.
   PubMed Web of Science ®Google Scholar

Website

• http://en.wikipedia.org/wiki/Schisandra_chinensisDefinition of Schisandra chinensis. From Wikipedia, the free encyclopedia. Access 7 October 2006.
   Google Scholar